| Ident. | Authors (with country if any) | Title |
|---|
| 000D82 (2013) |
Laura Y. Cabrera [Canada] ; Emily L. Evans [États-Unis] ; Roy H. Hamilton [États-Unis] | Ethics of the electrified mind: Defining issues and perspectives on the principled use of brain stimulation in medical research and clinical care |
| 000D92 (2013) |
Jean-François Daneault [Canada] ; Benoit Carignan [Canada] ; Abbas F. Sadikot [Canada] ; Michel Panisset [Canada] ; Christian Duval [Canada] | Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia? |
| 000E10 (2013) |
Wendy R. Galpern [États-Unis] ; Christopher S. Coffey [États-Unis] ; Alberto Albanese [Italie] ; Ken Cheung [États-Unis] ; Cynthia L. Comella [États-Unis] ; Dixie J. Ecklund [États-Unis] ; Stanley Fahn [États-Unis] ; Joseph Jankovic [États-Unis] ; Karl Kieburtz [États-Unis] ; Anthony E. Lang [Canada] ; Michael P. Mcdermott [États-Unis] ; Jeremy M. Shefner [États-Unis] ; Jan K. Teller [États-Unis] ; John L. P. Thompson [États-Unis] ; Sharon D. Yeatts [États-Unis] ; H. A. Jinnah [États-Unis] | Designing Clinical Trials for Dystonia |
| 000E26 (2013) |
Harvey B. Sarnat | Clinical neuropathology practice guide 5-2013: markers of neuronal maturation |
| 000E27 (2013) |
Jean-Paul Soucy [Canada] ; Robert Bartha [Canada] ; Christian Bocti [Canada] ; Michael Borrie [Canada] ; Amer M. Burhan [Canada] ; Robert Laforce [Canada] ; Pedro Rosa-Neto [Canada] | Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012 |
| 000E39 (2013) |
Matthis Synofzik [Allemagne] ; Anne S. Soehn [Allemagne] ; Janina Gburek-Augustat [Allemagne] ; Julia Schicks [Allemagne] ; Kathrin N. Karle [Allemagne] ; Rebecca Schüle [Allemagne] ; Tobias B. Haack [Allemagne] ; Martin Schöning [Allemagne] ; Saskia Biskup [Allemagne] ; Sabine Rudnik-Schöneborn [Allemagne] ; Jan Senderek [Allemagne] ; Karl-Titus Hoffmann [Allemagne] ; Patrick Macleod [Canada] ; Johannes Schwarz [Allemagne] ; Benjamin Bender [Allemagne] ; Stefan Krüger [Allemagne] ; Friedmar Kreuz [Allemagne] ; Peter Bauer [Allemagne] ; Ludger Schöls [Allemagne] | Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum |
| 000E47 (2013) |
Jean-François Daneault [Canada] ; Benoit Carignan ; Abbas F. Sadikot ; Christian Duval | Are quantitative and clinical measures of bradykinesia related in advanced Parkinson's disease? |
| 000E67 (2013) |
Lehana Thabane [Canada] ; Lawrence Mbuagbaw [Canada] ; Shiyuan Zhang [Canada] ; Zainab Samaan [Canada] ; Maura Marcucci [Canada] ; Chenglin Ye [Canada] ; Marroon Thabane [Canada] ; Lora Giangregorio [Canada] ; Brittany Dennis [Canada] ; Daisy Kosa [Canada] ; Victoria Borg Debono [Canada] ; Rejane Dillenburg [Canada] ; Vincent Fruci [Canada] ; Monica Bawor [Canada] ; Juneyoung Lee [Corée du Sud] ; George Wells [Canada] ; Charles H. Goldsmith [Canada] | A tutorial on sensitivity analyses in clinical trials: the what, why, when and how |
| 000E73 (2013) |
Zahinoor Ismail [Canada] ; Chetachi A. Emeremni [États-Unis] ; Patricia R. Houck [États-Unis] ; Sati Mazumdar [États-Unis] ; Jules Rosen [États-Unis] ; Tarek K. Rajji [Canada] ; Bruce G. Pollock [Canada, États-Unis] ; Benoit H. Mulsant [Canada, États-Unis] | A Comparison of the E-BEHAVE-AD, NBRS and NPI in Quantifying Clinical Improvement in the Treatment of Agitation and Psychosis Associated with Dementia |
| 000E92 (2013) |
Antoine Duquette [Canada] ; Bernard Brais [Canada] ; Jean-Pierre Bouchard [Canada] ; Jean Mathieu [Canada] | Clinical presentation and early evolution of spastic ataxia of Charlevoix‐Saguenay |
| 000F06 (2013) |
Lorraine V. Kalia [Canada] ; Suneil K. Kalia [Canada] ; Pamela J. Mclean ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | α‐Synuclein oligomers and clinical implications for Parkinson disease |
| 000F38 (2013) |
Jonathan Fuller [Canada] | Rhetoric and argumentation: how clinical practice guidelines think |
| 000F79 (2013) |
Vjera Holthoff [Allemagne] ; Steven Ferris [États-Unis] ; Serge Gauthier [Canada] ; Ralf Ihl [Allemagne] ; Philippe Robert [France] ; Bengt Winblad [Suède] ; Kati Sternberg [Allemagne] ; Frank Tennigkeit [Suisse] | Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open‐label, single‐arm, multicenter clinical study |
| 001029 (2013) |
Sonia Franciosi [Canada] ; Yaein Shim [Canada] ; Margaret Lau [Canada] ; Michael R. Hayden [Canada] ; Blair R. Leavitt [Canada] | A systematic review and meta‐analysis of clinical variables used in Huntington disease research |
| 001102 (2012) |
Michael D. Sage [Canada] ; Pamela J. Bryden ; Eric A. Roy ; Quincy J. Almeida | The relationship between the grooved pegboard test and clinical motor symptom evaluation across the spectrum of Parkinson's disease severity. |
| 001238 (2012) |
Jonathan Kimmelman [Canada] | Ethics, ambiguity aversion, and the review of complex translational clinical trials. |
| 001271 (2012) |
Gregory Costain [Canada] ; Anne S. Bassett [Canada] | Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era |
| 001342 (2012) |
Bradley Osterman [Canada] ; Michel Sylvain [Canada] ; Sylvain Chouinard [Canada] ; Geneviève Bernard [Canada] | Tremor‐ataxia with central hypomyelination (TACH): Dystonia as a new clinical feature |
| 001476 (2012) |
Roger Kurlan [États-Unis] ; Giovanna Crespi [États-Unis] ; Barbara Coffey [États-Unis] ; Kirsten Mueller-Vahl [Allemagne] ; Stephen Koval [États-Unis] ; Glen Wunderlich [Canada] | A multicenter randomized placebo‐controlled clinical trial of pramipexole for Tourette's syndrome |
| 001503 (2012) |
Anthony N. Carlsen [Canada] ; Dana Maslovat [Canada] ; Ian M. Franks [Canada] | Preparation for voluntary movement in healthy and clinical populations: Evidence from startle : Neurophysiology of the Brainstem |
| 001544 (2012) |
Evelyne Matteau [Canada] ; Nicolas Dupre [Canada] ; Mélanie Langlois [Canada] ; Pierre Provencher [Canada] ; Martine Simard [Canada] | Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia |
